| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.52B | 2.28B | 2.32B | 2.30B | 2.11B |
| Gross Profit | 383.68M | 845.89M | 374.45M | 868.65M | 830.91M |
| EBITDA | 313.36M | 310.55M | 333.39M | 386.80M | 371.06M |
| Net Income | 136.57M | 122.01M | 148.72M | 208.62M | 206.84M |
Balance Sheet | |||||
| Total Assets | 2.82B | 2.75B | 2.81B | 2.99B | 2.95B |
| Cash, Cash Equivalents and Short-Term Investments | 495.76M | 509.43M | 583.94M | 711.72M | 844.66M |
| Total Debt | 619.15M | 641.10M | 633.20M | 702.80M | 705.63M |
| Total Liabilities | 1.17B | 1.16B | 1.15B | 1.24B | 1.23B |
| Stockholders Equity | 1.65B | 1.60B | 1.66B | 1.75B | 1.72B |
Cash Flow | |||||
| Free Cash Flow | 232.25M | 199.97M | 220.04M | 159.50M | 194.59M |
| Operating Cash Flow | 269.23M | 246.82M | 272.82M | 217.34M | 239.03M |
| Investing Cash Flow | -8.19M | -37.10M | -255.44M | -70.58M | 353.22M |
| Financing Cash Flow | -228.92M | -233.79M | -342.29M | -289.54M | -193.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £2.76B | 8.02 | 11.47% | 3.58% | -2.44% | -6.43% | |
68 Neutral | £1.76B | 13.32 | 8.38% | 3.99% | 5.75% | 5.86% | |
67 Neutral | £172.99M | 5.60 | 5.64% | 6.70% | 8.83% | 27.20% | |
64 Neutral | £190.95M | 0.64 | 7.92% | 6.53% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
47 Neutral | £98.68M | -1.82 | -47.73% | ― | -2.08% | -9.83% |